European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Bio2Skin, a novel biomaterial for medical skin adhesives

Descrizione del progetto

Adesivi intelligenti e senza colla per uso medico

Oggigiorno, adesivi e cerotti per uso medico sono ampiamente utilizzati. Tuttavia, gli adesivi utilizzati nei dispositivi medici sono sintetici e spesso provocano dermatiti o addirittura lesioni quando vengono staccati. Il progetto Bio2Skin, finanziato dall’UE, mira a sviluppare prodotti sani e sicuri per la pelle umana. Proteggeranno anche la pelle dalle cosiddette lesioni cutanee correlate agli adesivi medicali (MARSI, Medical Adhesive-Related Skin Injury). Il progetto si baserà su nuovi materiali rivoluzionari quali i polimeri senza colla, altamente biocompatibili e chimicamente modificati, che non danneggiano la pelle offrendo al contempo fini proprietà di adesione. I primi test del prodotto sono molto promettenti per il mercato degli adesivi medici.

Obiettivo

Bio2Skin is a revolutionary new generation of medical-grade adhesives with a wide range of uses in the application of medical devices and wound dressings. This disruptive and unique adhesive will provide a welcome alternative to the current glues used in the application of devices and dressings to the skin which tend to provoke severe skin problems.

Currently available adhesives are viscous materials made of synthetic chemicals that fill the skin irregularities, to augment the contact area. When peeled off, they provoke dermatitis, which is caused by the removal of a large amount of epidermis cells. Bio2Skin allows the development of a line of products that can provide effective protection against Medical Adhesive-Related Skin Injury (MARSI).

Bio2Skin is based on our unique research on glue-less naturally occurring chemicals results in adhesion to surfaces materially different. Our novel material results from the combination of highly biocompatible chemically-modified polymers that display excellent adhesion properties equivalent or better to current chemical glue-based adhesives.

As our product is based with nature in mind, Bio2Skin binds to the natural features of skin offering good adhesion properties without damaging the skin either during use or upon removal, reducing or even eliminating the skin damage caused by the continuous use of current adhesives.

Small-scale pre-clinical tests at the Centre for Nanotechnology and Smart Materials (CeNTI Portugal) so far have been extremely promising, and we believe we can make a significant impact in the medical adhesive market which is projected to reach €10 billion by 2019.

Invito a presentare proposte

H2020-EIC-SMEInst-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEInst-2018-2020-1

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

BESTHEALT H4U UNIPESSOAL LDA
Contribution nette de l'UE
€ 50 000,00
Indirizzo
PRACA CONDE DE AGROLONGO, EDIFICIO GNRATION, 123
4700 312 BRAGA
Portogallo

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Continente Norte Cávado
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 71 429,00